Changes in thyroid hormone concentrations during neonatal extracorporeal membrane oxygenation

Area of Science:

• Neonatal critical care
• Endocrinology
• Pediatric intensive care

Background:

• Thyroid hormone concentrations can be significantly altered in critically ill patients.
• Neonatal extracorporeal membrane oxygenation (ECMO) is a life-support measure that may impact thyroid function.
• Understanding thyroid hormone dynamics during ECMO is crucial for appropriate patient management.

Purpose of the Study:

• To investigate changes in thyroid hormone concentrations in neonates undergoing ECMO.
• To assess the potential need for thyroxine supplementation during ECMO therapy.

Main Methods:

• A study involving 21 neonates treated with ECMO.
• Measurement of age-specific standard deviation scores (SDS) for free thyroxine (FT4), total thyroxine (TT4), reverse triiodothyronine (rT3), total triiodothyronine (TT3), thyroid-stimulating hormone (TSH), and thyroxine-binding globulin (TBG) at six time points.
• Analysis of data using general linear models.

Main Results:

• Baseline thyroid hormone levels were indicative of non-thyroidal illness syndrome (NTIS).
• During ECMO, TT4, TSH, and TBG levels initially declined, followed by a rise in TSH, TT4, and TT3.
• Free thyroxine (FT4) levels remained stable within the normal range throughout ECMO.

Conclusions:

• Pre-ECMO thyroid hormone profiles suggest NTIS.
• The observed changes during ECMO may indicate a spontaneous recovery of the hypothalamic-pituitary-thyroid axis.
• Stable FT4 levels suggest that thyroxine therapy is not required for neonates on ECMO.